Literature DB >> 8353403

Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ.

C W Zimmermann1, F Eblen.   

Abstract

If weakness of the eye muscles remains the only symptom of myasthenia gravis (MG) for more than 2 years, the condition is operationally defined as ocular MG (OMG). A number of clinical, genetic, and immunological differences between this variant and generalized MG (GMG) have been described. We analyzed repertoires of autoantibodies against proteins of skeletal and extraocular muscle in sex- and age-matched groups of patients with either GMG or OMG (n = 10 in each group). All GMG sera detected a group of three proteins larger than 200 kDa which were not detected by any of the OMG sera. Two components with apparent molecular weights of 50 and 60 kDa were stained by seven of the ten OMG sera but by none of the GMG group. These antigens are probably soluble, cytoplasmatic proteins of the eye muscle. OMG sera, furthermore, detected a protein of about 45 kDa in the pellet fraction of eye muscle but failed to do so after adsorption with skeletal muscle fractions. We conclude that OMG and GMG sera contain autoantibodies of different specificities. Our findings further support immunological heterogeneity in MG.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353403     DOI: 10.1007/bf00180057

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  26 in total

1.  The thymus in seronegative myasthenia gravis patients.

Authors:  N Willcox; M Schluep; M A Ritter; J Newsom-Davis
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

5.  [Oculomotor forms of myasthenia].

Authors:  F Contamin; J F Doubrere; S Thorel
Journal:  J Fr Ophtalmol       Date:  1984       Impact factor: 0.818

6.  Antibodies not directed against the acetylcholine receptor in myasthenia gravis. An immunoblot study.

Authors:  C W Zimmermann; G Weiss
Journal:  J Neuroimmunol       Date:  1987-10       Impact factor: 3.478

7.  Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.

Authors:  A Vincent; J Newsom-Davis
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

8.  Thymectomy in myasthenia with pure ocular symptoms.

Authors:  F Schumm; H Wiethölter; A Fateh-Moghadam; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

9.  Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.

Authors:  K Kida; M Hayashi; I Yamada; H Matsuda; J Yoshinaga; S Takami; S Yashiki; S Sonoda
Journal:  Ann Neurol       Date:  1987-03       Impact factor: 10.422

10.  Co-expression of multiple myosin heavy chain genes, in addition to a tissue-specific one, in extraocular musculature.

Authors:  D F Wieczorek; M Periasamy; G S Butler-Browne; R G Whalen; B Nadal-Ginard
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

View more
  3 in total

1.  IgA autoantibodies against human eye muscle antigen detected by western blotting and immunohistochemical methods in Graves' disease.

Authors:  I Molnár; V Kaczur; A Boros; G Krajczár; C Balázs
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

Review 2.  Immunological mechanisms in glaucoma.

Authors:  F Grus; D Sun
Journal:  Semin Immunopathol       Date:  2008-03-11       Impact factor: 9.623

3.  Modulation of B cell regulatory molecules CD22 and CD72 in myasthenia gravis and multiple sclerosis.

Authors:  Jiayin Lu; Jing Li; Tai-qing Zhu; Longbo Zhang; Yuzhong Wang; Fa-fa Tian; Huan Yang
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.